Association between anti-thymocyte globulin administration and cytomegalic virus infection and/or CMV disease in cadaveric renal allograft recipients.
Siu
C W
CW
Division of Nephrology, Department of Medicine, Queen Mary Hospital, University of Hong Kong, Room 411, Professional Block, Queen Mary Hospital, Pokfulam Road, Hong Kong, Hong Kong.
Chan
T M
TM
Li
F K
FK
Choy
B Y
BY
Lui
S L
SL
Lo
C Y
CY
Tang
S
S
Lo
W K
WK
Lai
K N
KN
D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D002102:Cadaver; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use; D003586:Cytomegalovirus Infections / Q000453:epidemiology*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D011183:Postoperative Complications / Q000821:virology; D011239:Prednisolone / Q000627:therapeutic use; D012044:Regression Analysis; D012189:Retrospective Studies; D012307:Risk Factors; D014019:Tissue Donors; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011239:Prednisolone; D003404:Creatinine; D001379:Azathioprine